Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with ASND: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
ASND
Ascendis Pharma A/S
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
ASND
Ascendis Pharma A/S
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ASND: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only ASND
3
NVO
Novo Nordisk A/S
customer
—
Teijin
unlisted
customer
—
VISEN Pharmaceuticals
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
LLY
ELI Lilly & Co
Change
1,417.89
▲
+0.60%
· post 1,419.27
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
ASND
Ascendis Pharma A/S
Change
256.19
▲
+2.40%
· post 256.19
Closed
Nov 4 '26
Mkt cap
$15.5B
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 4 '26
LLY
ELI Lilly & Co
vs
ASND
Ascendis Pharma A/S
1,417.89
▲
+0.60%
post 1,419.27
Price
256.19
▲
+2.40%
post 256.19
$1.3T
Mkt cap
$15.5B
Q3 FY26
$24.4B
Revenue
—
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,417.89
▲
+0.60%
vs
ASND
256.19
▲
+2.40%
Closed
Nov 4 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
ASND, dashed